No significant correlations were found between individual candidate mRNA biomarkers or BDNF and neuropsychological symptoms within MSUD or UCD patients, and the only BCKDK deficiency patient included in the study precludes this type of analysis. This evidence concerns the gene BCKDK and maple syrup urine disease.